Neuronopathy, distal hereditary motor, autosomal recessive 10

disease
On this page

Summary

Neuronopathy, distal hereditary motor, autosomal recessive 10 (MONDO:0957876) is a disease caused by VRK1 (GenCC Strong), with 1 cohort gene.

At a glance

  • Causal gene: VRK1 (GenCC Strong)
  • Cohort genes: 1
  • ClinVar variants: 27

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical nameneuronopathy, distal hereditary motor, autosomal recessive 10
Mondo IDMONDO:0957876
OMIM620542
DOIDDOID:0081429
UMLSC5882703
MedGen1846713
GARD0026890
Is cancer (heuristic)no

Data availability: 27 ClinVar variants · 1 GenCC gene-disease record.

Disease family

Classification path: disease › human disease › disease by etiologic mechanism › disease of genetic or genomic mechanism › hereditary disease › autosomal genetic disease › autosomal recessive diseaseneuronopathy, distal hereditary motor, autosomal recessiveneuronopathy, distal hereditary motor, autosomal recessive 10

Related subtypes (11): autosomal recessive distal spinal muscular atrophy 1, autosomal recessive distal spinal muscular atrophy 2, neuronopathy, distal hereditary motor, autosomal recessive 3, neuronopathy, distal hereditary motor, autosomal recessive 4, neuronopathy, distal hereditary motor, autosomal recessive 5, neuronopathy, distal hereditary motor, autosomal recessive 8, neuronopathy, distal hereditary motor, autosomal recessive 7, early-onset progressive encephalopathy-spastic ataxia-distal spinal muscular atrophy syndrome, spinal muscular atrophy, distal, autosomal recessive, 6, neuronopathy, distal hereditary motor, autosomal recessive 9, neuronopathy, distal hereditary motor, autosomal recessive 11, with spasticity

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

ClinVar germline variants

27 retrieved; paginated sample, class counts are floors:

9 pathogenic/likely pathogenic, 6 likely pathogenic, 6 conflicting classifications of pathogenicity, 5 uncertain significance, 1 pathogenic

ClinVarVariant (HGVS)GeneClassificationReview
1453431NM_003384.3(VRK1):c.1124G>A (p.Trp375Ter)VRK1Pathogenic/Likely pathogeniccriteria provided, multiple submitters, no conflicts
1970380NM_003384.3(VRK1):c.1144dup (p.Glu382fs)VRK1Pathogenic/Likely pathogeniccriteria provided, multiple submitters, no conflicts
209204NM_003384.3(VRK1):c.356A>G (p.His119Arg)VRK1Pathogenic/Likely pathogeniccriteria provided, multiple submitters, no conflicts
209205NM_003384.3(VRK1):c.961C>T (p.Arg321Cys)VRK1Pathogenic/Likely pathogeniccriteria provided, multiple submitters, no conflicts
2164156NM_003384.3(VRK1):c.1081_1084del (p.Glu361fs)VRK1Pathogenic/Likely pathogeniccriteria provided, multiple submitters, no conflicts
464942NM_003384.3(VRK1):c.883_886del (p.Lys295fs)VRK1Pathogenic/Likely pathogeniccriteria provided, multiple submitters, no conflicts
521856NM_003384.3(VRK1):c.1160G>A (p.Arg387His)VRK1Pathogenic/Likely pathogeniccriteria provided, multiple submitters, no conflicts
7497NM_003384.3(VRK1):c.1072C>T (p.Arg358Ter)VRK1Pathogeniccriteria provided, multiple submitters, no conflicts
846403NM_003384.3(VRK1):c.660T>A (p.Cys220Ter)VRK1Pathogenic/Likely pathogeniccriteria provided, multiple submitters, no conflicts
848771NM_003384.3(VRK1):c.1159+1G>AVRK1Pathogenic/Likely pathogeniccriteria provided, multiple submitters, no conflicts
1505827NM_003384.3(VRK1):c.1094del (p.Ser365fs)VRK1Likely pathogeniccriteria provided, multiple submitters, no conflicts
3576914NM_003384.3(VRK1):c.3dup (p.Pro2fs)VRK1Likely pathogeniccriteria provided, multiple submitters, no conflicts
3576915NM_003384.3(VRK1):c.287-2A>GVRK1Likely pathogeniccriteria provided, single submitter
3576916NM_003384.3(VRK1):c.882del (p.Asn294fs)VRK1Likely pathogeniccriteria provided, single submitter
3780789NM_003384.3(VRK1):c.286+2T>GVRK1Likely pathogeniccriteria provided, single submitter
4291770NM_003384.3(VRK1):c.865dup (p.Cys289fs)VRK1Likely pathogeniccriteria provided, single submitter
197213NM_003384.3(VRK1):c.266G>A (p.Arg89Gln)VRK1Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
218924NM_003384.3(VRK1):c.706G>A (p.Val236Met)VRK1Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
30243NM_003384.3(VRK1):c.397C>T (p.Arg133Cys)VRK1Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
533538NM_003384.3(VRK1):c.6del (p.Arg3fs)VRK1Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
617789NM_003384.3(VRK1):c.761G>T (p.Trp254Leu)VRK1Conflicting classifications of pathogenicityno assertion criteria provided
619020NM_003384.3(VRK1):c.656G>T (p.Arg219Ile)VRK1Conflicting classifications of pathogenicityno assertion criteria provided
1251999NM_003384.3(VRK1):c.236C>T (p.Pro79Leu)VRK1Uncertain significancecriteria provided, multiple submitters, no conflicts
1977286NM_003384.3(VRK1):c.512A>G (p.His171Arg)VRK1Uncertain significancecriteria provided, multiple submitters, no conflicts
3775425NM_003384.3(VRK1):c.574C>A (p.Gln192Lys)VRK1Uncertain significancecriteria provided, single submitter
3775426NM_003384.3(VRK1):c.248A>G (p.Glu83Gly)VRK1Uncertain significancecriteria provided, single submitter
4277661NM_003384.3(VRK1):c.665A>G (p.Asp222Gly)VRK1Uncertain significancecriteria provided, single submitter

Genes & proteins

Mendelian disease overlap and somatic drivers

GenCC: 8 · Orphanet: 2 · OMIM-shared: 0 · Dual-evidence (GWAS+Mendelian): 0

GenCC gene–disease validity (cohort genes)

the Disease column is the GenCC-asserted condition — a cohort gene’s strongest validity may be for a related predisposition syndrome.

GeneClassificationInheritanceDiseaseRecords
VRK1StrongAutosomal recessiveneuronopathy, distal hereditary motor, autosomal recessive 108

Orphanet rare-disease linkage (cohort genes)

GeneOrphanet IDRare disease
VRK1Orphanet:2254Pontocerebellar hypoplasia type 1
VRK1Orphanet:423894Microcephaly-complex motor and sensory axonal neuropathy syndrome

Cohort genes → proteins

1 cohort genes, 1 distinct canonical proteins.

Evidence partition

SubsetGenes
multi_evidence1

Cohort genes (full)

SymbolHGNCEnsemblUniProtNameEvidence
VRK1HGNC:12718ENSG00000100749Q99986Serine/threonine-protein kinase VRK1gencc,clinvar

Cohort function summary

Lead sentence per gene, UniProt-curated.

SymbolProtein nameFunction (lead sentence)
VRK1Serine/threonine-protein kinase VRK1Serine/threonine kinase involved in the regulation of key cellular processes including the cell cycle, nuclear condensation, transcription regulation, and DNA damage response.

Protein-family classification

Druggable: 1 · Difficult: 0 · Unknown: 0 · Druggable fraction: 1.0

Family distribution

Cohort families vs a genome-wide background (hypergeometric, BH-FDR; fold = observed/expected). Counts kept; sorted by enrichment, so the catch-all Other/Unknown bucket no longer leads.

FamilyGenesFoldFDR
Kinase127.7×0.036

Per-gene assignment

SymbolFamilyDruggable?ECInterPro (top 3)
VRK1KinaseyesProt_kinase_dom, Ser/Thr_kinase_AS, Kinase-like_dom_sf

Expression context

Cohort genes with no expression data: 0.

1 cohort gene are a single-cell marker in ≥1 SCXA experiment.

Breadth distribution (Bgee present_calls)

BucketGenes
narrow (1-5 tissues)0
moderate (6-20)0
broad (>20)1
unknown0

Top tissues across cohort

TissueCohort genes
bone marrow1
oocyte1
secondary oocyte1

Per-gene tissue summary (top 30)

SymbolBgee breadthFANTOM5 breadthSCXATop tissues
VRK1286ubiquitousmarkeroocyte, bone marrow, secondary oocyte

Protein interactions among cohort

Intra-cohort edges: 0.

Hub genes (top 10 by interactor count)

SymbolInteractor count
VRK13,022

Structural data

PDB: 1 · AlphaFold-only: 0 · No structure: 0

Cohort genes with PDB structures (top 30)

SymbolUniProtPDB entries
VRK1Q9998626

Function

Pathway analysis

Distinct Reactome pathways touched by cohort: 2. Enrichment computed across 1 evidence-associated genes (1 with Reactome annotation).

Pathways by enrichment

Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 1 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.

PathwayCohort genesFoldFDRSample cohort genes
Initiation of Nuclear Envelope (NE) Reformation1601.0×0.002VRK1
Nuclear Envelope Breakdown1456.8×0.002VRK1

GO biological processes by enrichment

Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 1 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.

GO termCohort genesFoldFDRSample cohort genes
positive regulation of protein localization to chromatin15617.3×0.001VRK1
Cajal body organization14213.0×0.001VRK1
Golgi disassembly12808.7×0.001VRK1
mitotic nuclear membrane disassembly11872.4×0.002VRK1
regulation of neuron migration1624.1×0.004VRK1
protein autophosphorylation1145.3×0.014VRK1
neuron projection development1122.1×0.014VRK1
chromatin remodeling173.0×0.020VRK1
protein phosphorylation168.0×0.020VRK1
DNA damage response153.5×0.022VRK1
cell division146.2×0.024VRK1
signal transduction116.1×0.062VRK1

Therapeutics

Drug target analysis

Approved (phase 4): 0 · Phase ≥3: 0 · Phased (≥1): 0 · Undrugged: 1

Druggability breadth: 1 of 1 evidence-associated genes (100%) have a ChEMBL target (buckets above are over the deeply-mined display cohort).

Top cohort targets by molecule count

SymbolMoleculesMax phase
VRK100

Bioactivity and enzyme data

Enzyme cohort genes (≥1 EC): 0.

Cohort genes with ChEMBL bioactivity (full, sorted by assay count)

SymbolAssaysType breakdown
VRK174Binding:74

Pharmacogenomics

Cohort genes with a PharmGKB record: 1; with CPIC/DPWG dosing guidelines: 0.

No cohort gene has a CPIC/DPWG genotype-guided dosing guideline (PharmGKB).

Chemical tractability of cohort targets

0 approved/phased compounds have measured bioactivity against a cohort gene (and aren’t yet in disease-level trials). This is a research / tractability signal, NOT a therapeutic recommendation — a bioactivity row often reflects off-target or screening binding (e.g. promiscuous kinase inhibitors against a cohort kinase), implying no disease mechanism.

Druggability pyramid

Cohort genes binned by druggability tier (high → low):

TierDefinitionGenesSymbols
AApproved (phase 4 drug)0
BPhased (≥1) drug, not yet approved0
CDruggable family + PDB, no drug1VRK1
DDruggable family + AlphaFold only, no drug0
EDifficult family or no structure, no drug0

Undrugged target profiles

1 cohort genes are undrugged. Ranked by ‘starting-point quality’ (assay depth + drugged-partner adjacency).

SymbolChEMBL assaysDrugged partners (top 3)
VRK174

Clinical trials & evidence

Clinical trials

Clinical trials: 0.